FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 304:862-866 April 9, 1981 Number 15 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To assess the efficacy and safety of verapamil in variant angina pectoris, we entered 16 patients in a double-blind, randomized trial of nine months, duration. During treatment with verapamil, the frequency of angina fell substantially (12.6 +/- 25.9 chest pains per week with placebo, 1.7 +/- 2.8 pains per week with verapamil, mean +/- S.D.; P less than 0.01), as did the use of nitroglycerin tablets (14.4 +/- 34.4 tablets per week with placebo, 2.1 +/- 3.3 tablets per week with verapamil; P less than 0.05). The number of hospitalizations for clinical instability was significantly lower with verapamil (P less than 0.01). The number of episodes of transient ST-segment deviation during treatment with verapamil was reduced (33.1 +/- 39.3 ST-segment deviations per week with placebo, 7.7 +/- 11.7 deviations per week with verapamil; P less than 0.01). Verapamil caused no side effects forcing a reduction in dosage or a discontinuation. We conclude that verapamil is safe and effective in the therapy of variant angina pectoris.

This article has been cited by other articles:

• Mishra, P. K. (2006). Variations in presentation and various options in management of variant angina.. Eur. J. Cardiothorac. Surg. 29: 748-759 [Abstract] [Full Text]  
• Sueda, S., Kohno, H., Fukuda, H., Watanabe, K., Ochi, N., Kawada, H., Uraoka, T. (2003). Limitations of Medical Therapy in Patients With Pure Coronary Spastic Angina. Chest 123: 380-386 [Abstract] [Full Text]  
• Zvara, D. A. (2001). Treatment of Perioperative Myocardial Ischemia. SEMIN CARDIOTHORAC VASC ANESTH 5: 166-183 [Abstract]  
• Winniford, M. D., Willerson, J. T., Hillis, L. D. (1982). Calcium Antagonists in the Treatment of Individuals with Ischemic Heart Disease. ANGIOLOGY 33: 522-539 [Abstract]